UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000999 |
|---|---|
| Receipt number | R000001159 |
| Scientific Title | Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide Mixed with IFA and IFN-alpha for Patients with Oral Cancer (Phase I clinical study) |
| Date of disclosure of the study information | 2008/01/28 |
| Last modified on | 2021/02/14 11:36:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/01/28 23:06:52 | ||
| 2 | Update | 2021/02/10 14:07:54 | Recruitment status Date of IRB Last follow-up date |
|
| 3 | Update | 2021/02/14 11:30:43 | Publication of results Number of participants that the trial has enrolled |
|
| 4 | Update | 2021/02/14 11:36:50 | Control Type of intervention |
